Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,213 results that match your search.22,213 results
  • The Community trade mark will soon mark its 12th anniversary. Since it was launched, the EU has seen many changes - and some of them pose challenges for the CTM system. James Nurton reports
  • Trade mark offices and legislators in the Asia-Pacific region are moving beyond traditional trade marks, but progress is slow. Peter Ollier explains how far they have got
  • Austria TRADE MARK PROSECUTION Tier 1 Sonn & Partner Tier 2 Patentanwälte Puchberger, Berger & Partner Schönherr Rechtsanwälte Torggler & Hofinger Wiltschek Rechtsanwälte Tier 3 Barger, Piso & Partner Beer & Partner Patentanwalt Dr Thomas M Haffner Patentanwälte Schütz und Partner
  • Egypt TRADE MARK PROSECUTION Tier 1 Abu-Ghazaleh Intellectual Property (AGIP) Hoda Abdel Hadi & Partners Tier 2 Youssef Hafez Law Office Hoda A Serageldin SABA
  • Australia TRADE MARK PROSECUTION Tier 1 Davies Collison Cave Griffith Hack Phillips Ormonde & Fitzpatrick Spruson & Ferguson Tier 2 F B Rice & Co Freehills Shelston IP Watermark Tier 3 Allens Arthur Robinson Blake Dawson Corrs Chambers Westgarth Tier 4 Baker & McKenzie Clayton Utz Deacons Gilbert + Tobin Mallesons Stephen Jaques Middletons Minter Ellison Pizzeys Wray & Associates Tier 5 Banki Haddock Fiora Callinans Cullen & Co Fisher Adams Kelly Halford & Co Madderns Nicholas Weston
  • Could proposals for a global standard for patent valuation provide greater transparency and clarity for IP owners? James Nurton reports
  • The worldwide Erbitux patent dispute reached the end of the road with a settlement between the parties
  • The French IP office has launched a range of activities to help SMEs protect and exploit their IP rights. Benoît Battistelli, director-general of INPI, explains more
  • Dutch biotechnology company Crucell signed a licence agreement with Korean-based ISU ABXIS over STAR, a technology used for the production of recombinant human antibodies and proteins. This deal covers the research and development of the technology and includes an option for a commercial licence.
  • As competition between US presidential contenders hots up, Managing IP looks at where the main candidates stand on life sciences issues